Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China

Summary by Globe Newswire
SHENZHEN, CHINA, Dec. 11, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that on 11...

7 Articles

Taiwan NewsTaiwan News
+4 Reposted by 4 other sources
Lean Left

CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China | Taiwan News | Dec. 11, 2025 20:43

Dec. 11, 2025 20:43

·Taiwan
Read Full Article
chicagoheadlines.uschicagoheadlines.us

CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China – Chicago Headlines

Open the article to view the coverage from chicagoheadlines.us

Read Full Article
dirhongkong.comdirhongkong.com

Kangzhe Pharmaceutical (0867)'s Innovative Drug for Acute Ischemic Stroke, Y-3 for Injection, Has Been Accepted in China – Dir Hongkong

Shenzhen, December 11, 2025 – (Asia Pacific Business News via SeaPRwire)

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
34% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

dirhongkong.com broke the news in on Thursday, December 11, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

China icon

China

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal